Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Grace DiBonaventura Beyer"'
Autor:
Dena H. Jaffe, Lingfeng Yang, Joana E. Matos, Gail Fernandes, Kristy Iglay, Ira Gantz, Grace Dibonaventura Beyer, Swapnil Rajpathak
Publikováno v:
Current Medical Research and Opinion. 36:377-386
Objective: Type 2 diabetes (T2D) is a prevalent health problem. Oral agents, with the exception of metformin, are often discontinued with the initiation of insulin. The objective was to understand ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586fb5ff630aa1e75e95a946bc8ff687
https://doi.org/10.1080/03007995.2019.1698416
https://doi.org/10.1080/03007995.2019.1698416
Autor:
Richard W. Joseph, Reshma Shinde, Edward A. Witt, Enrique Basurto, Grace DiBonaventura Beyer, Frank Xiaoqing Liu, Scot Ebbinghaus
Publikováno v:
Patient preference and adherence
Frank Xiaoqing Liu,1 Edward A Witt,2 Scot Ebbinghaus,1 Grace DiBonaventura Beyer,2 Reshma Shinde,1 Enrique Basurto,2 Richard W Joseph3 1Merck & Co., Inc., Kenilworth, NJ, USA; 2Kantar Health, New York, NY, USA; 3Mayo Clinic, Jacksonville, FL, USA Pur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::797baced937a7a510d05257616abe115
http://europepmc.org/articles/PMC5565374
http://europepmc.org/articles/PMC5565374
Autor:
Gail Fernandes, Joana E. Matos, Kristy Iglay, Ira Gantz, Dena H. Jaffe, Grace Dibonaventura Beyer, Swapnil Rajpathak
Publikováno v:
Diabetes. 68
At the time of insulin initiation, physicians often discontinue oral therapies in patients with T2D. A recent randomized clinical trial demonstrated continuing sitagliptin, a DPP-4i, results in a clinically meaningful greater reduction in HbA1c witho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f84e90f2125c3c7db94acd225943d798
https://doi.org/10.2337/db19-1258-p
https://doi.org/10.2337/db19-1258-p
Autor:
Frank Xiaoqing Liu, Edward A. Witt, Grace DiBonaventura Beyer, Richard W. Joseph, Enrique Basurto, Scot Ebbinghaus
Publikováno v:
Cancer Nursing
Background Understanding the perceptions of patients and oncology nurses about the relative importance of benefits and risks associated with newer treatments of advanced melanoma can help to inform clinical decision-making. Objectives The aims of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::894e7687ad1326a1985f1c4c62794d98
https://pubmed.ncbi.nlm.nih.gov/29076867
https://pubmed.ncbi.nlm.nih.gov/29076867